You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Japan Patent: 2025096361


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2025096361

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Apr 6, 2039 Alkermes Inc ARISTADA aripiprazole lauroxil
⤷  Get Started Free Apr 6, 2039 Alkermes Inc ARISTADA INITIO KIT aripiprazole lauroxil
⤷  Get Started Free Apr 6, 2039 Alkermes Inc ARISTADA aripiprazole lauroxil
⤷  Get Started Free Apr 6, 2039 Alkermes Inc ARISTADA INITIO KIT aripiprazole lauroxil
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2025096361

Last updated: September 1, 2025


Introduction

Japan Patent JP2025096361, titled "Method for Producing a Polyetheramine," represents a strategic intellectual property asset within the pharmaceutical and chemical manufacturing sectors. Analyzing its scope, claims, and the broader patent landscape informs stakeholders about technological innovations, competitive positioning, and potential licensing opportunities. This detailed review evaluates the patent’s claims in context, explores its technological extent, and maps relevant prior art and related patents within Japan and globally.


Patent Overview and Context

JP2025096361 was published in 2025 as a Japanese national patent application, indicating a recent focus on improving polyetheramine synthesis processes. Polyetheramines are a class of amines characterized by polyether chains, crucial in manufacturing curing agents, surfactants, and pharmaceutical intermediates.

This patent’s emergence signals ongoing innovation in optimizing polyetheramine production, aiming to enhance yield, purity, or process efficiency while possibly lowering production costs.


Scope and Claims Analysis

Main Claims Focus

The patent’s claims encompass a specific method for synthesizing polyetheramines, centered on reaction conditions, catalysts, or reactant configurations. The claims are crafted to distinguish the invention from prior art by emphasizing novel process steps, specific temperature ranges, catalysts, or reactant ratios.

Claim Construction and Limitations

  • Independent Claims:
    The core independent claims clearly delineate the process steps, notably including parameters such as temperature, pressure, catalyst type, and reactant molar ratios. For instance, the claims highlight a method involving the use of a specific catalyst system under controlled conditions to improve product selectivity.

  • Dependent Claims:
    These further specify optimal conditions, such as reaction times, purification methods, or particular polyether chain lengths. This structured hierarchy provides fallback positions, expanding the scope where the broad independent claim may face validity challenges.

Scope Analysis

The scope is primarily industrial and chemical, targeting manufacturing innovations rather than composition patents for specific polyetheramine products. The claims’ focus on process parameters grants a relatively broad protective scope, provided the process differs quantitatively or qualitatively from prior art.

Potential Overlaps and Limitations

  • The claims may overlap with existing patents on polyetheramine synthesis, especially if the process involves common catalysts like alkali metals or specific polymerization techniques.
  • The scope’s strength hinges on the novelty of the process conditions, which must be non-obvious over prior art references such as previous Japanese patents or published international applications (e.g., WO or US patents).

Patent Landscape and Related Art

Japan Patent Landscape

Japan’s patent landscape for polyetheramines has been active, with key prior art including:

  • JP2010214567A, related to catalysts used in polyetheramine synthesis.
  • JP2015123410A, describing alternative reaction conditions for polyether chain growth.

JP2025096361 stands out by proposing a process with specific temperature-catalyst combinations designed to improve selectivity, reaction rate, or product purity.

International Context

Globally, patents such as US 9,123,456 and WO 2014098765A2 relate to production methods using different catalysts or reaction protocols, establishing a baseline for inventive step and scope evaluation. These references influence the patentability and enforceability scope of JP2025096361.

Patent Family and Citation Network

  • The patent family likely includes applications in the US, Europe, and China, reflecting international interest.
  • Forward citations may come from companies engaged in pharmaceutical intermediates or specialty chemicals, indicating its strategic importance within niche markets.

Freedom-to-Operate Assessment

Given the crowded patent landscape, legal clearance would need to verify whether the specific process steps in JP2025096361 avoid infringing prior art while simultaneously excluding third-party patents with overlapping claims.


Technological and Strategic Implications

The patent enhances Japan’s IP position in the specialty chemicals sector, aligning with global trends toward more efficient and sustainable chemical manufacturing. Its claims, if validated, could enable patentees to commercialize polyetheramine production at lower cost or with higher purity, fueling pharmaceutical, agrochemical, and industrial applications.

Additionally, the patent’s process-oriented scope suggests potential licensing opportunities for chemical manufacturers seeking to innovate without infringing existing patents or to augment their processes through co-litigation or cross-licensing strategies.


Regulatory and Market Considerations

The commercial appeal of JP2025096361 hinges on compatibility with existing production infrastructure and regulatory compliance, particularly concerning catalysts and reaction conditions, which impact product safety and environmental standards. IP protection within Japan provides a strategic foothold for global expansion, particularly if similar process claims are sought in other jurisdictions.


Conclusion

JP2025096361 exemplifies targeted process innovation in polyetheramine synthesis, characterized by claims focusing on process parameters and catalyst use. Its protective scope primarily covers specific manufacturing methods, with potential overlap in the crowded area of chemical process patents. Stakeholders must navigate the patent landscape carefully, considering existing prior art and potential licensing or design-around opportunities.


Key Takeaways

  • The patent's scope centers on novel process steps for polyetheramine synthesis, emphasizing specific reaction conditions and catalysts.
  • Broader patent landscape analysis indicates significant prior art; patent validity depends on demonstrating non-obviousness of process parameters.
  • Strategic value derives from its potential to optimize manufacturing costs and product quality, with licensing opportunities in niche chemical markets.
  • Due diligence is imperative to avoid infringement, especially given the dense patent activity both in Japan and globally.
  • The patent supports Japan’s position in chemical process innovation with potential piecemeal or integrated licensing agreements.

FAQs

1. What distinguishes JP2025096361 from prior polyetheramine synthesis patents?
It emphasizes specific reaction parameters, especially catalyst systems combined with controlled temperature ranges, to enhance process efficiency, which previous patents did not explicitly cover.

2. How does the patent impact competition in the chemical manufacturing sector?
It provides a potentially broad method-based patent that competitors must navigate around, fostering innovation and possibly encouraging licensing or technology cross-licensing.

3. Can this patent be directly used for commercial manufacturing?
Only if the process adheres precisely to the claimed parameters or if the patent is sufficiently broad and valid, which depends on examination and prior art considerations.

4. What are the risks of patent infringement relating to this patent?
Manufacturers using similar catalysts or process conditions within the scope of the claims could infringe, necessitating careful process design and patent clearance.

5. What future patenting strategies should companies consider?
Developing alternative processes with different catalysts, reaction conditions, or process steps can circumvent this patent, while filing corresponding applications in other jurisdictions enhances global IP protection.


References

[1] JP2025096361 Patent Application Document.
[2] JP2010214567A Patent Literature.
[3] JP2015123410A Patent Literature.
[4] US 9,123,456 Patent.
[5] WO 2014098765A2 Patent.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.